iTANK-technology platform
A universal CAR T-cell technology platform, compatible with any CAR T-cell therapy for a multi-targeted attack on solid tumors.
iTANK-platformElicera's strengths are based on a deep understanding of how cells and viruses can be genetically engineered to trigger a powerful immune response to cancer.
Di Yu, Head of Technical Operations and co-founder, tells more about Elicera in the film.
